graphic_speedingPatientsToTrials@2x-1

Speeding Patients to Trials

The challenge facing BioPharma and CROs is finding patients to fill trials. The complexity and siloing of patient data means eligible patients are slow to be identified, or worse, missed.

In addition, the vast majority of patients are seen in community settings and their care teams are left out of the clinical research loop altogether.

What if you could increase your visibility with healthcare providers and sponsored sites to accelerate trials to completion?

How Viper Works
narrow-windows-for-enrollment
Deep Lens and Viper Software

Deep Lens gives you a sharp focus on patients

Our AI-driven cloud platform, VIPER, identifies patients at the time of diagnosis, accelerating trial recruitment to bring game-changing therapies to market sooner.

Embedded at institutions around the globe, VIPER integrates and filters patient data to match cases against inclusion and exclusion criteria and flags potential molecular testing to be completed.

In addition, VIPER pulls in patients from community settings to nearby trial sites. VIPER provides real-time dashboard and alerting capabilities to proactively track trial performance and new case activity at the study and site levels to compress study timelines.

How Deep Lens increases patient enrollment

VIPER is a unique patient recruitment tool specifically designed to inform and educate care teams of potential trial participants earlier than alternative methods through optimizing their enrollment process and not allowing patients to slip through the cracks with molecular testing notifications and community oncologist engagement.

bioPharma_patientEnrollment@2x

AIVITA Biomedical is at the forefront of developing clinical-stage cell-based treatments in oncology.  We know that there are patients that would qualify to participate in our studies but never get the opportunity to consider the studies as a care option.  I am encouraged that Deep Lens has developed a promising solution to tackle some of the underlying obstacles that are challenging to our sites, that will help AIVITA Biomedical speed our therapies to market faster.

James Langford
Vice President of Clinical Operations, AIVITA Biomedical

See VIPER In action

The combination of integrated notification and education engines, with unique pre-enrollment workflow support, prevents early misses and optimizes the enrollment process to capture more patients.
Schedule a demo to see more.

Get Demo

  1. The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey M. Kelsey Kirkwood, Amy Hanley, Suanna S. Bruinooge, Elizabeth Garrett-Mayer, Laura A. Levit, Caroline Schenkel, Jerome E. Seid, Blase N. Polite, and Richard L. Schilsky
  2. Journal of Oncology Practice 2018 14:7, e412-e420
  3. Jon Hess, "Web-based Patient Recruitment," (White Paper) Cutting Edge Information, http://www.cuttingedgeinfo.com/process/?ref=122.